Thursday, April 20, 2017

Gene Therapy - Table of Contents alert Volume 24 Issue 4

If you are unable to see the message below, click here to view.
Gene Therapy

Vigene Bioproduction

Make Gene Therapy Affordable Offering vectors for pre-clinical and clinical applications Proven track record in preclinical and GMP Phase I/II clinical materials used in vaccine, cell & gene therapy applications for over 13 years Perfect for meeting small-scale aseptic filling in our BSL-3 viral production area

Learn more


Volume 24, Issue 4 (April 2017)

In this issue
Original Articles
Short Communications

Also new
A supplement to
Nature Biotechnology | Nature Reviews Drug Discovery

Check out the latest issue of BioPharma Dealmakers for the latest dealmaking opportunities, and editorials on personalized cancer vaccines based on tumor-specific neoantigens, the expanding network of microbiome partnerships, and impending growth spurt of the dermatology market.

Download the issue for FREE
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed

Original Articles


Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer

W Zhou, S Dai, H Zhu, Z Song, Y Cai, J B Lee, Z Li, X Hu, B Fang, C He and X Huang

Gene Ther 2017 24: 199-207; advance online publication, January 11, 2017; 10.1038/gt.2017.2

Abstract | Full Text

Balanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity OPEN

K Mølgaard, M Compte, N Nuñez-Prado, S L Harwood, L Sanz and L Alvarez-Vallina

Gene Ther 2017 24: 208-214; advance online publication, January 11, 2017; 10.1038/gt.2017.3

Abstract | Full Text

Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression OPEN

M L Katz, G C Johnson, S B Leach, B G Williamson, J R Coates, R E H Whiting, D P Vansteenkiste and M S Whitney

Gene Ther 2017 24: 215-223; advance online publication, February 2, 2017; 10.1038/gt.2017.4

Abstract | Full Text

IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats

H Yi, T Iida, S Liu, D Ikegami, Q Liu, A Iida, D A Lubarsky and S Hao

Gene Ther 2017 24: 224-233; advance online publication, March 16, 2017; 10.1038/gt.2017.11

Abstract | Full Text

Modulation of digital flexor tendon healing by vascular endothelial growth factor gene transfection in a chicken model

W F Mao, Y F Wu, Q Q Yang, Y L Zhou, X T Wang, P Y Liu and J B Tang

Gene Ther 2017 24: 234-240; advance online publication, February 21, 2017; 10.1038/gt.2017.12

Abstract | Full Text

Short Communications


Neutralizing antibodies against adeno-associated viruses in Sjögren’s patients: implications for gene therapy

A Corden, B Handelman, H Yin, A Cotrim, I Alevizos and J A Chiorini

Gene Ther 2017 24: 241-244; advance online publication, February 2, 2017; 10.1038/gt.2017.1

Abstract | Full Text

Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1G93A ALS rat but has adverse side effects OPEN

G M Thomsen, M Alkaslasi, J-P Vit, G Lawless, M Godoy, G Gowing, O Shelest and C N Svendsen

Gene Ther 2017 24: 245-252; advance online publication, March 9, 2017; 10.1038/gt.2017.9

Abstract | Full Text

MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain OPEN

L Samaranch, B Blits, W San Sebastian, P Hadaczek, J Bringas, V Sudhakar, M Macayan, P J Pivirotto, H Petry and K S Bankiewicz

Gene Ther 2017 24: 253-261; advance online publication, March 16, 2017; 10.1038/gt.2017.14

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

nature publishing group

No comments: